Professor, Laboratory Director
Stanford
Palo Alto, California, United States
Dr. Stuart A. Scott is a Professor in the Department of Pathology at Stanford University and Director of the Stanford Medicine Clinical Genomics Laboratory, where he oversees genomic test innovation and implementation. Dr. Scott is certified by the American Board of Medical Genetics and Genomics (ABMGG) in both Clinical Molecular Genetics and Genomics, and Clinical Cytogenetics and Genomics, and his translational research interests include human genomics, pharmacogenomics, cytogenomics, long-read sequencing, and the implementation of genomic medicine. Dr. Scott is on the steering committees of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Pharmacogene Variation (PharmVar) Consortium, and is an invited member of the Association for Molecular Pathology (AMP) Pharmacogenomics Working Group, International Union of Basic and Clinical Pharmacology (IUPHAR), and other national consortia on genomic medicine (ClinGen, eMERGE, IGNITE, UDN, GREGoR). He has published over 150 peer-reviewed manuscripts and book chapters on clinical genomics, and is an invited Scientific Editor of the Medical Genetics Summaries (MGS) from the NCBI/NIH/NLM.
Platform Presentations of Selected Genetics Abstracts
Thursday, November 21, 2024
2:30 PM – 3:30 PM PST
AMP/ACMG/CPIC/CAP/DPWG/ESPT/PharmGKB/PharmVar DPYD Genotyping Recommendations
Saturday, November 23, 2024
1:15 PM – 2:15 PM PST
Role of Gender Identification in Genetic Testing
Saturday, November 23, 2024
2:30 PM – 4:00 PM PST
Disparities in Genetic Testing
Saturday, November 23, 2024
4:15 PM – 5:15 PM PST